  Major advances in public health have resulted from disease prevention.
However, prevention of a new infectious disease by vaccination or
pharmaceuticals is made difficult by the slow process of vaccine and drug
development. We propose an additional intervention that allows rapid control of
emerging infectious diseases, and can also be used to eradicate diseases that
rely almost exclusively on human-to-human transmission. The intervention is
based on (1) testing every individual for the disease, (2) repeatedly, and (3)
isolation of infected individuals. We show here that at a sufficient rate of
testing, the reproduction number is reduced below 1.0 and the epidemic will
rapidly collapse. The approach does not rely on strong or unrealistic
assumptions about test accuracy, isolation compliance, population structure or
epidemiological parameters, and its success can be monitored in real time by
following the test positivity rate. In addition to the compliance rate and
false negatives, the required rate of testing depends on the design of the
testing regime, with concurrent testing outperforming random sampling. Provided
that results are obtained rapidly, the test frequency required to suppress an
epidemic is monotonic and near-linear with respect to R0, the infectious
period, and the fraction of susceptible individuals. The testing regime is
effective against both early phase and established epidemics, and additive to
other interventions (e.g. contact tracing and social distancing). It is also
robust to failure: any rate of testing reduces the number of infections,
improving both public health and economic conditions. These conclusions are
based on rigorous analysis and simulations of appropriate epidemiological
models. A mass-produced, disposable test that could be used at home would be
ideal, due to the optimal performance of concurrent tests that return immediate
results.
